Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 273

1.

Peripheral nerve transfers change target muscle structure and function.

Bergmeister KD, Aman M, Muceli S, Vujaklija I, Manzano-Szalai K, Unger E, Byrne RA, Scheinecker C, Riedl O, Salminger S, Frommlet F, Borschel GH, Farina D, Aszmann OC.

Sci Adv. 2019 Jan 2;5(1):eaau2956. doi: 10.1126/sciadv.aau2956. eCollection 2019 Jan.

2.

Ten-Year Clinical Outcomes From a Trial of Three Limus-Eluting Stents With Different Polymer Coatings in Patients With Coronary Artery Disease.

Kufner S, Joner M, Thannheimer A, Hoppmann P, Ibrahim T, Mayer K, Cassese S, Laugwitz KL, Schunkert H, Kastrati A, Byrne RA; ISAR-TEST 4 (Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents) Investigators.

Circulation. 2019 Jan 15;139(3):325-333. doi: 10.1161/CIRCULATIONAHA.118.038065.

PMID:
30586724
3.

[2018 ESC/EACTS Guidelines on myocardial revascularization].

Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, Juni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferović PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO.

Kardiol Pol. 2018;76(12):1585-1664. doi: 10.5603/KP.2018.0228. Polish. No abstract available.

4.

Prognostic Impact of Periprocedural Myocardial Infarction in Patients Undergoing Elective Percutaneous Coronary Interventions.

Koskinas KC, Ndrepepa G, Räber L, Karagiannis A, Kufner S, Zanchin T, Hieber J, Hunziker L, Mayer K, Byrne RA, Heg D, Windecker S, Kastrati A.

Circ Cardiovasc Interv. 2018 Dec;11(12):e006752. doi: 10.1161/CIRCINTERVENTIONS.118.006752.

PMID:
30545257
5.

Prospective, randomized trial of bioresorbable scaffolds vs. everolimus-eluting stents in patients undergoing coronary stenting for myocardial infarction: the Intracoronary Scaffold Assessment a Randomized evaluation of Absorb in Myocardial Infarction (ISAR-Absorb MI) trial.

Byrne RA, Alfonso F, Schneider S, Maeng M, Wiebe J, Kretov E, Bradaric C, Rai H, Cuesta J, Rivero F, Hoppmann P, Schlichtenmaier J, Christiansen EH, Cassese S, Joner M, Schunkert H, Laugwitz KL, Kastrati A.

Eur Heart J. 2019 Jan 7;40(2):167-176. doi: 10.1093/eurheartj/ehy710.

PMID:
30520980
6.

Outcome after new generation single-layer polytetrafluoroethylene-covered stent implantation for the treatment of coronary artery perforation.

Kufner S, Schacher N, Ferenc M, Schlundt C, Hoppmann P, Abdel-Wahab M, Mayer K, Fusaro M, Byrne RA, Kastrati A.

Catheter Cardiovasc Interv. 2018 Nov 23. doi: 10.1002/ccd.27979. [Epub ahead of print]

PMID:
30467994
7.

The ESC Congress 2018 and the legacy of Eugene Braunwald.

Byrne RA.

EuroIntervention. 2018 Nov 20;14(10):1067-1068. doi: 10.4244/EIJV14I10A190. No abstract available.

8.

Comparison of Vascular Closure Devices Versus Manual Compression After Femoral Artery Puncture in Women.

Gewalt SM, Helde SM, Ibrahim T, Mayer K, Schmidt R, Bott-Flügel L, Hoppe K, Ott I, Hieber J, Morath T, Byrne RA, Kufner S, Cassese S, Hoppmann P, Fusaro M, Schunkert H, Laugwitz KL, Kastrati A, Schüpke S; Instrumental Sealing of Arterial Puncture Site—CLOSURE Device Versus Manual Compression (ISAR-CLOSURE) Trial Investigators.

Circ Cardiovasc Interv. 2018 Aug;11(8):e006074. doi: 10.1161/CIRCINTERVENTIONS.117.006074.

PMID:
30354782
9.

High-Speed Rotational Atherectomy Versus Modified Balloons Prior to Drug-Eluting Stent Implantation in Severely Calcified Coronary Lesions.

Abdel-Wahab M, Toelg R, Byrne RA, Geist V, El-Mawardy M, Allali A, Rheude T, Robinson DR, Abdelghani M, Sulimov DS, Kastrati A, Richardt G.

Circ Cardiovasc Interv. 2018 Oct;11(10):e007415. doi: 10.1161/CIRCINTERVENTIONS.118.007415. Erratum in: Circ Cardiovasc Interv. 2018 Oct;11(10):e000040.

PMID:
30354632
10.

Strengths and Limitations of Real World Data in Patients Treated With Coronary Stents.

Byrne RA, Colleran R, Kastrati A.

Circ Cardiovasc Interv. 2018 Sep;11(9):e007239. doi: 10.1161/CIRCINTERVENTIONS.118.007239. No abstract available.

PMID:
30354605
11.

Early maternal feeding practices: Associations with overweight later in childhood.

Haszard JJ, Russell CG, Byrne RA, Taylor RW, Campbell KJ.

Appetite. 2019 Jan 1;132:91-96. doi: 10.1016/j.appet.2018.10.008. Epub 2018 Oct 9.

PMID:
30308224
12.

Endovascular stenting in femoropopliteal arteries.

Cassese S, Byrne RA.

Lancet. 2018 Oct 27;392(10157):1491-1493. doi: 10.1016/S0140-6736(18)32339-0. Epub 2018 Sep 24. No abstract available.

PMID:
30262333
13.

2018 ESC/EACTS Guidelines on myocardial revascularization.

Sousa-Uva M, Neumann FJ, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, Jüni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferovic PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO; ESC Scientific Document Group .

Eur J Cardiothorac Surg. 2019 Jan 1;55(1):4-90. doi: 10.1093/ejcts/ezy289. No abstract available.

PMID:
30165632
14.

2018 ESC/EACTS Guidelines on myocardial revascularization.

Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, Jüni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferovic PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO; ESC Scientific Document Group .

Eur Heart J. 2019 Jan 7;40(2):87-165. doi: 10.1093/eurheartj/ehy394. No abstract available.

PMID:
30165437
15.

The use and impact of clinical practice guidelines in interventional cardiology.

Byrne RA.

EuroIntervention. 2018 Aug 20;14(6):607-608. doi: 10.4244/EIJV14I6A106. No abstract available.

16.

Sex and Long-Term Outcomes After Implantation of Absorb Bioresorbable Vascular Scaffold for Treatment of Coronary Artery Disease.

Baquet M, Hoppmann P, Grundmann D, Schmidt W, Kufner S, Theiss HD, Brunner S, Wiebe J, Eickhoff M, Jochheim D, Byrne RA, Laugwitz KL, Schunkert H, Massberg S, Kastrati A, Mehilli J.

EuroIntervention. 2018 Aug 14. pii: EIJ-D-18-00603. doi: 10.4244/EIJ-D-18-00603. [Epub ahead of print]

17.

Neoatherosclerosis in Patients With Coronary Stent Thrombosis: Findings From Optical Coherence Tomography Imaging (A Report of the PRESTIGE Consortium).

Joner M, Koppara T, Byrne RA, Castellanos MI, Lewerich J, Novotny J, Guagliumi G, Xhepa E, Adriaenssens T, Godschalk TC, Malik N, Alfonso F, Tada T, Neumann FJ, Desmet W, Ten Berg JM, Gershlick AH, Feldman LJ, Massberg S, Kastrati A; Prevention of PRESTIGE Investigators.

JACC Cardiovasc Interv. 2018 Jul 23;11(14):1340-1350. doi: 10.1016/j.jcin.2018.02.029.

PMID:
30025727
18.

Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions.

Räber L, Mintz GS, Koskinas KC, Johnson TW, Holm NR, Onuma Y, Radu MD, Joner M, Yu B, Jia H, Meneveau N, de la Torre Hernandez JM, Escaned J, Hill J, Prati F, Colombo A, Di Mario C, Regar E, Capodanno D, Wijns W, Byrne RA, Guagliumi G.

EuroIntervention. 2018 Aug 20;14(6):656-677. doi: 10.4244/EIJY18M06_01.

19.

The discovery of X-rays, the fate of atomic bomb survivors, and the impact on modern interventional cardiology.

Byrne RA.

EuroIntervention. 2018 Jun 20;14(2):129-131. doi: 10.4244/EIJV14I2A18. No abstract available.

20.

Long-term effectiveness and safety of transcatheter closure of patent foramen ovale compared with antithrombotic therapy alone: a meta-analysis of six randomised clinical trials and 3,560 patients with reconstructed time-to-event data.

Giacoppo D, Caronna N, Frangieh AH, Michel J, Andò G, Tarantini G, Kasel AM, Capodanno D, Byrne RA.

EuroIntervention. 2018 Oct 20;14(8):857-867. doi: 10.4244/EIJ-D-18-00341.

21.

Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions.

Räber L, Mintz GS, Koskinas KC, Johnson TW, Holm NR, Onuma Y, Radu MD, Joner M, Yu B, Jia H, Meneveau N, de la Torre Hernandez JM, Escaned J, Hill J, Prati F, Colombo A, di Mario C, Regar E, Capodanno D, Wijns W, Byrne RA, Guagliumi G; ESC Scientific Document Group .

Eur Heart J. 2018 Sep 14;39(35):3281-3300. doi: 10.1093/eurheartj/ehy285.

PMID:
29790954
22.

Percutaneous coronary and structural interventions in women: a position statement from the EAPCI Women Committee.

Chieffo A, Buchanan GL, Mehilli J, Capodanno D, Kunadian V, Petronio AS, Mikhail GW, Capranzano P, Gonzal N, Karam N, Manzo-Silberman S, Schüpke S, Byrne RA, Capretti G, Appelman Y, Morice MC, Presbitero P, Radu M, Mauri J.

EuroIntervention. 2018 Dec 7;14(11):e1227-e1235. doi: 10.4244/EIJ-D-18-00225.

23.

Evaluating the importance of sham-controlled trials in the investigation of medical devices in interventional cardiology.

Byrne RA, Capodanno D, Mahfoud F, Fajadet J, Windecker S, Jüni P, Baumbach A, Wijns W, Haude M.

EuroIntervention. 2018 Aug 20;14(6):708-715. doi: 10.4244/EIJ-D-18-00481.

24.

Efficacy Over Time With Drug-Eluting Stents in Saphenous Vein Graft Lesions.

Colleran R, Kufner S, Mehilli J, Rosenbeiger C, Schüpke S, Hoppmann P, Joner M, Mankerious N, Fusaro M, Cassese S, Abdel-Wahab M, Neumann FJ, Richardt G, Ibrahim T, Schunkert H, Laugwitz KL, Kastrati A, Byrne RA; ISAR-CABG Investigators.

J Am Coll Cardiol. 2018 May 8;71(18):1973-1982. doi: 10.1016/j.jacc.2018.03.456.

PMID:
29724350
25.

Markers of Reperfusion and Long-Term (8-Year) Prognosis after Primary Percutaneous Coronary Intervention.

Ndrepepa G, Byrne RA, Cassese S, Fusaro M, Colleran R, Hieber J, Laugwitz KL, Schunkert H, Kastrati A.

Am J Cardiol. 2018 Jul 1;122(1):39-46. doi: 10.1016/j.amjcard.2018.03.353. Epub 2018 Apr 9.

PMID:
29706204
26.

What interventionalists can learn from the aviation industry.

Byrne RA.

EuroIntervention. 2018 Apr 20;13(17):1977-1979. doi: 10.4244/EIJV13I17A321. No abstract available.

27.

Challenges in Patients with Diabetes: Improving Clinical Outcomes After Percutaneous Coronary Intervention Through EVOlving Stent Technology.

Byrne RA, Banai S, Colleran R, Colombo A.

Interv Cardiol. 2018 Jan;13(1):40-44. doi: 10.15420/icr.2017:27:1.

28.

PCI in Patients with Diabetes: Role of the Cre8 Drug-eluting Stent.

Byrne RA, Eeckhout E, Sardella G, Stella P, Verheye S.

Interv Cardiol. 2017 May;12(1):13-17. doi: 10.15420/icr.2016:28:2.

29.

Randomised comparison of vascular response to biodegradable polymer sirolimus eluting and permanent polymer everolimus eluting stents: An optical coherence tomography study.

Koppara T, Tada T, Xhepa E, Kufner S, Byrne RA, Ibrahim T, Laugwitz KL, Kastrati A, Joner M.

Int J Cardiol. 2018 May 1;258:42-49. doi: 10.1016/j.ijcard.2018.01.011.

PMID:
29544956
30.

Current Use of Intracoronary Imaging in Interventional Practice - Results of a European Association of Percutaneous Cardiovascular Interventions (EAPCI) and Japanese Association of Cardiovascular Interventions and Therapeutics (CVIT) Clinical Practice Survey.

Koskinas KC, Nakamura M, Räber L, Colleran R, Kadota K, Capodanno D, Wijns W, Akasaka T, Valgimigli M, Guagliumi G, Windecker S, Byrne RA.

Circ J. 2018 Apr 25;82(5):1360-1368. doi: 10.1253/circj.CJ-17-1144. Epub 2018 Mar 15.

31.

Current use of intracoronary imaging in interventional practice - Results of a European Association of Percutaneous Cardiovascular Interventions (EAPCI) and Japanese Association of Cardiovascular Interventions and Therapeutics (CVIT) Clinical Practice Survey.

Koskinas KC, Nakamura M, Räber L, Colleran R, Kadota K, Capodanno D, Wijns W, Akasaka T, Valgimigli M, Guagliumi G, Windecker S, Byrne RA.

EuroIntervention. 2018 Jul 20;14(4):e475-e484. doi: 10.4244/EIJY18M03_01.

32.

Outcomes of patients treated with ultrathin-strut biodegradable polymer sirolimus-eluting stents versus fluoropolymer-based everolimus-eluting stents: a meta-analysis of randomised trials.

Cassese S, Ndrepepa G, Byrne RA, Kufner S, Lahmann AL, Mankerious N, Xhepa E, Laugwitz KL, Schunkert H, Fusaro M, Kastrati A, Joner M.

EuroIntervention. 2018 Jun 20;14(2):224-231. doi: 10.4244/EIJ-D-18-00024.

33.

Evidence-based medicine, transparency and reproducibility in research, and challenges for peer review.

Byrne RA.

EuroIntervention. 2018 Feb 20;13(14):1615-1617. doi: 10.4244/EIJV13I14A259. No abstract available.

34.

Vascular response to percutaneous coronary intervention with biodegradable-polymer vs. new-generation durable-polymer drug-eluting stents: a meta-analysis of optical coherence tomography imaging trials.

Cassese S, Xhepa E, Ndrepepa G, Kufner S, Colleran R, Giacoppo D, Koppara T, Mankerious N, Byrne RA, Laugwitz KL, Schunkert H, Fusaro M, Kastrati A, Joner M.

Eur Heart J Cardiovasc Imaging. 2018 Nov 1;19(11):1294-1301. doi: 10.1093/ehjci/jex334.

PMID:
29300853
35.

Postprocedural high-sensitivity troponin T and prognosis in patients with non-ST-segment elevation myocardial infarction treated with early percutaneous coronary intervention.

Harada Y, Koskinas KC, Ndrepepa G, Räber L, Braun S, Zanchin T, Kufner S, Hunziker L, Byrne RA, Heg D, Kastrati A, Windecker S.

Cardiovasc Revasc Med. 2018 Jul;19(5 Pt A):480-486. doi: 10.1016/j.carrev.2017.11.010. Epub 2017 Nov 22.

PMID:
29292015
36.

Special article 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS.

Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, Jüni P, Kastrati A, Kolh P, Mauri L, Montalescot G, Neumann FJ, Petricevic M, Roffi M, Steg PG, Windecker S, Zamorano JL.

Rev Esp Cardiol (Engl Ed). 2018 Jan;71(1):42. doi: 10.1016/j.rec.2017.11.020. English, Spanish. No abstract available. Erratum in: Rev Esp Cardiol (Engl Ed). 2018 Apr 11;:.

PMID:
29277234
37.

Observational Study of Platelet Reactivity in Patients Presenting With ST-Segment Elevation Myocardial Infarction Due to Coronary Stent Thrombosis Undergoing Primary Percutaneous Coronary Intervention: Results From the European PREvention of Stent Thrombosis by an Interdisciplinary Global European Effort Registry.

Godschalk TC, Byrne RA, Adriaenssens T, Malik N, Feldman LJ, Guagliumi G, Alfonso F, Neumann FJ, Trenk D, Joner M, Schulz C, Steg PG, Goodall AH, Wojdyla R, Dudek D, Wykrzykowska JJ, Hlinomaz O, Zaman AG, Curzen N, Dens J, Sinnaeve P, Desmet W, Gershlick AH, Kastrati A, Massberg S, Ten Berg JM; PRESTIGE Investigators.

JACC Cardiovasc Interv. 2017 Dec 26;10(24):2548-2556. doi: 10.1016/j.jcin.2017.09.019.

38.

Fallout from the ORBITA trial - is angioplasty in a spin?

Byrne RA.

EuroIntervention. 2017 Dec 20;13(11):1253-1254. doi: 10.4244/EIJV13I11A195. No abstract available.

39.

[2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS.]

Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, Jüni P, Kastrati A, Kolh P, Mauri L, Montalescot G, Neumann FJ, Peticevic M, Roffi M, Steg PG, Windecker S, Zamorano JL.

Kardiol Pol. 2017;75(12):1217-1299. doi: 10.5603/KP.2017.0224. Polish. No abstract available.

40.

Targeted inhibition of Janus kinases abates interfon gamma-induced invasive behaviour of fibroblast-like synoviocytes.

Karonitsch T, Beckmann D, Dalwigk K, Niederreiter B, Studenic P, Byrne RA, Holinka J, Sevelda F, Korb-Pap A, Steiner G, Smolen JS, Pap T, Kiener HP.

Rheumatology (Oxford). 2018 Mar 1;57(3):572-577. doi: 10.1093/rheumatology/kex426.

PMID:
29228301
41.

Comparative efficacy of two paclitaxel-coated balloons with different excipient coatings in patients with coronary in-stent restenosis: A pooled analysis of the Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In-Stent Restenosis 3 and 4 (ISAR-DESIRE 3 and ISAR-DESIRE 4) trials.

Colleran R, Joner M, Kufner S, Altevogt F, Neumann FJ, Abdel-Wahab M, Bohner J, Valina C, Richardt G, Zrenner B, Cassese S, Ibrahim T, Laugwitz KL, Schunkert H, Kastrati A, Byrne RA; Intracoronary Stenting and Angiographic Results: Optimizing treatment of Drug Eluting Stent In-Stent Restenosis 3 and 4 (ISAR-DESIRE 3 and ISAR-DESIRE 4) investigators.

Int J Cardiol. 2018 Feb 1;252:57-62. doi: 10.1016/j.ijcard.2017.11.076. Epub 2017 Nov 28.

PMID:
29203209
42.

Transfemoral Approach for Coronary Angiography and Intervention: A Collaboration of International Cardiovascular Societies.

Damluji AA, Nelson DW, Valgimigli M, Windecker S, Byrne RA, Cohen F, Patel T, Brilakis ES, Banerjee S, Mayol J, Cantor WJ, Alfonso CE, Rao SV, Moscucci M, Cohen MG.

JACC Cardiovasc Interv. 2017 Nov 27;10(22):2269-2279. doi: 10.1016/j.jcin.2017.08.035.

43.

Is There an Association Between Noncontact Anterior Cruciate Ligament Injuries and Decreased Hip Internal Rotation or Radiographic Femoroacetabular Impingement? A Systematic Review.

Boutris N, Byrne RA, Delgado DA, Hewett TE, McCulloch PC, Lintner DM, Harris JD.

Arthroscopy. 2018 Mar;34(3):943-950. doi: 10.1016/j.arthro.2017.08.302. Epub 2017 Nov 20. Review.

PMID:
29162364
44.

Mechanisms of Very Late Bioresorbable Scaffold Thrombosis: The INVEST Registry.

Yamaji K, Ueki Y, Souteyrand G, Daemen J, Wiebe J, Nef H, Adriaenssens T, Loh JP, Lattuca B, Wykrzykowska JJ, Gomez-Lara J, Timmers L, Motreff P, Hoppmann P, Abdel-Wahab M, Byrne RA, Meincke F, Boeder N, Honton B, O'Sullivan CJ, Ielasi A, Delarche N, Christ G, Lee JKT, Lee M, Amabile N, Karagiannis A, Windecker S, Räber L.

J Am Coll Cardiol. 2017 Nov 7;70(19):2330-2344. doi: 10.1016/j.jacc.2017.09.014.

45.

Case-based implementation of the 2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease.

Collet JP, Roffi M, Byrne RA, Costa F, Valgimigli M; Task Force for the Management of Dual Antiplatelet Therapy in Coronary Artery Disease of the European Society of Cardiology (ESC) ; ESC Scientific Document Group ; Task Force for the Management of Dual Antiplatelet Therapy in Coronary Artery Disease of the European Society of Cardiology (ESC) .

Eur Heart J. 2018 Jan 14;39(3):e1-e33. doi: 10.1093/eurheartj/ehx503. No abstract available.

PMID:
29088328
46.

Biodegradable polymer drug-eluting stents: caveat emptor.

Byrne RA, Schuster T.

Lancet. 2017 Oct 21;390(10105):1814-1816. doi: 10.1016/S0140-6736(17)32668-5. Epub 2017 Oct 19. No abstract available.

PMID:
29082870
47.

2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS.

Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, Jüni P, Kastrati A, Kolh P, Mauri L, Montalescot G, Neumann FJ, Petricevic M, Roffi M, Steg PG, Windecker S, Zamorano JL, Levine GN; ESC Scientific Document Group.

Eur J Cardiothorac Surg. 2018 Jan 1;53(1):34-78. doi: 10.1093/ejcts/ezx334. No abstract available.

PMID:
29045581
48.

Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).

Capodanno D, Petronio AS, Prendergast B, Eltchaninoff H, Vahanian A, Modine T, Lancellotti P, Sondergaard L, Ludman PF, Tamburino C, Piazza N, Hancock J, Mehilli J, Byrne RA, Baumbach A, Kappetein AP, Windecker S, Bax J, Haude M.

Eur Heart J. 2017 Dec 1;38(45):3382-3390. doi: 10.1093/eurheartj/ehx303. No abstract available.

49.

Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary.

Byrne RA, Stefanini GG, Capodanno D, Onuma Y, Baumbach A, Escaned J, Haude M, James S, Joner M, Jüni P, Kastrati A, Oktay S, Wijns W, Serruys PW, Windecker S.

Eur Heart J. 2018 May 7;39(18):1591-1601. doi: 10.1093/eurheartj/ehx488.

PMID:
29020259
50.

Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary.

Byrne RA, Stefanini GG, Capodanno D, Onuma Y, Baumbach A, Escaned J, Haude M, James S, Joner M, Jüni P, Kastrati A, Oktay S, Wijns W, Serruys PW, Windecker S.

EuroIntervention. 2018 Jan 20;13(13):1574-1586. doi: 10.4244/EIJ20170912-01.

Supplemental Content

Loading ...
Support Center